檢索結果 - Patrick Vermersch

Refine Results
  1. 1
    Social participation in patients with multiple sclerosis: correlations between disability and economic burden

    Social participation in patients with multiple sclerosis: correlations between disability and economic burden 由 Arnaud Kwiatkowski, Jean-Pierre Marissal, Madani Pouyfaucon, Patrick Vermersch, Patrick Hautecœur, B. Dervaux

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease.

    Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease. 由 D Caparros-Lefèbvre, S. Blond, Patrick Vermersch, N. Pécheux, J.D. Guieu, H Petit

    出版 1993
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?

    Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose? 由 Patrick Vermersch, Jeremy Hobart, Catherine Dive‐Pouletty, Sylvie Bozzi, Steven Hass, Patricia K. Coyle

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Diagnosis and treatment of progressive multiple sclerosis: A position paper

    Diagnosis and treatment of progressive multiple sclerosis: A position paper 由 Carlo Pozzilli, Maura Pugliatti, Patrick Vermersch, Nikolaos Grigoriadis, Mona Alkhawajah, Laura Airas, Celia Oreja‐Guevara

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients

    Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients 由 Floriane Calocer, Olivier Dejardin, Arnaud Kwiatkowski, Bertrand Bourre, Patrick Vermersch, Patrick Hautecœur, Guy Launoy, Gilles Defer

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Artificial intelligence and science of patient input: a perspective from people with multiple sclerosis

    Artificial intelligence and science of patient input: a perspective from people with multiple sclerosis 由 Anne Helme, Dipak Kalra, Giampaolo Brichetto, Guy Peryer, Patrick Vermersch, Helga Weiland, Angela White, Paola Zaratin

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Clinical effects of natalizumab on multiple sclerosis appear early in treatment course

    Clinical effects of natalizumab on multiple sclerosis appear early in treatment course 由 Ludwig Kappos, Paul O’Connor, Christopher H. Polman, Patrick Vermersch, Heinz Wiendl, Amy Pace, Annie Zhang, Christophe Hotermans

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study

    Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study 由 Patrick Vermersch, R. Benrabah, Nicolás Schmidt, Hélène Zephir, Pierre Clavelou, Cyrille Vongsouthi, Patrice Dubreuil, Alain Moussy, Olivier Hermine

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study

    Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study 由 Cristoforo Comi, Stuart D. Cook, Kottil Rammohan, Per Soelberg Sørensen, Patrick Vermersch, Abidemi Adeniji, Fernando Dangond, Gavin Giovannoni

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype

    Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype 由 Bruno Brochet, Pierre Clavelou, Gilles Defer, de Sèze, Céline Louapre, Éloi Magnin, Aurélie Ruet, Catherine Thomas-Antérion, Patrick Vermersch

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

    Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study 由 Gavin Giovannoni, Per Soelberg Sørensen, Stuart D. Cook, Kottil Rammohan, Peter Rieckmann, Gıancarlo Comı, Fernando Dangond, Abidemi Adeniji, Patrick Vermersch

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

    Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study 由 Gavin Giovannoni, Per Soelberg Sørensen, Stuart D. Cook, Kottil Rammohan, Peter Rieckmann, Gıancarlo Comı, Fernando Dangond, Christine Hicking, Patrick Vermersch

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder?

    Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? 由 Didier Leys, Jean‐Pierre Pruvo, Maxime Parent, Patrick Vermersch, G Soetaert, M Steinling, A. Delacourte, A. Défossez, A. Rapoport, J Clarisse

    出版 1991
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Neurologic Manifestations in Primary Sjögren Syndrome

    Neurologic Manifestations in Primary Sjögren Syndrome 由 S. Delalande, de Sèze, A.L. Fauchais, É. Hachulla, Tanya Stojkovic, D. Ferriby, Sylvain Dubucquoi, Jean‐Pierre Pruvo, Patrick Vermersch, Pierre‐Yves Hatron

    出版 2004
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

    Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. 由 Philip Scheltens, Didier Leys, Frederik Barkhof, D. Huglo, H. C. Weinstein, Patrick Vermersch, Michaël Kuiper, M Steinling, Erik Ch. Wolters, Jaap Valk

    出版 1992
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis

    Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis 由 Gıancarlo Comı, Stuart D. Cook, Gavin Giovannoni, Peter Rieckmann, Per Soelberg Sørensen, Patrick Vermersch, Andrew Galazka, Axel Nolting, Christine Hicking, Fernando Dangond

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review

    Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review 由 Óscar Fernández, Per Soelberg Sørensen, Gıancarlo Comı, Patrick Vermersch, Hans‐Peter Hartung, Letizia Leocani, Thomas Berger, Bart Van Wijmeersch, Celia Oreja‐Guevara

    出版 2024
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  18. 18
    Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper

    Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper 由 Susana Otero-Romero, Jaume Sastre‐Garriga, Cristoforo Comi, Hans-Peter Hartung, Per Soelberg Sørensen, Alan J. Thompson, Patrick Vermersch, Ralf Gold, Xavier Montalbán

    出版 2016
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  19. 19
    Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial

    Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial 由 Jerry S. Wolinsky, Xavier Montalbán, Stephen L. Hauser, Gavin Giovannoni, Patrick Vermersch, Corrado Bernasconi, Gurpreet Deol‐Bhullar, Hideki Garren, Peter Chin, Shibeshih Belachew, Ludwig Kappos

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

    A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis 由 Gavin Giovannoni, Gıancarlo Comı, Stuart D. Cook, Kottil Rammohan, Peter Rieckmann, Per Soelberg Sørensen, Patrick Vermersch, Peter Chang, Anthony Hamlett, Bruno Musch, Steven J. Greenberg

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: